S
Sionna Therapeutics Inc
NASDAQ:SION
Sionna Therapeutics Inc
NASDAQ:SION
Price:
37.89
USD
-2.57%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sionna Therapeutics Inc
NASDAQ:SION
|
US |
|
Birkenstock Holding PLC
NYSE:BIRK
|
UK |
|
M
|
Megaron SA
WSE:MEG
|
PL |
|
Maja Agung Latexindo PT Tbk
IDX:SURI
|
ID |
|
Innodata Inc
NASDAQ:INOD
|
US |
|
ViewRay Inc
OTC:VRAYQ
|
US |
|
S
|
Santam Ltd
JSE:SNT
|
ZA |
|
I
|
IONOS Group SE
XETRA:IOS
|
DE |
|
Eczacibasi Yatirim Holding Ortakligi AS
IST:ECZYT.E
|
TR |
|
B
|
Boeing Co
LSE:BOE
|
US |
|
K
|
Kitwave Group PLC
LSE:KITW
|
UK |
|
H
|
Hamayuu Co Ltd
TSE:7682
|
JP |
|
Seven Principles AG
XETRA:T3T1
|
DE |
|
A
|
Anheuser-Busch Inbev SA
SWB:1NBA
|
BE |
|
M
|
Mdwerks Inc
OTC:MDWK
|
US |
|
BIOLASE Inc
OTC:BIOLQ
|
US |
|
Shinsegae Inc
KRX:004170
|
KR |
|
Fiducial Real Estate SA
PAR:ORIA
|
FR |
|
Sgis Songshan Co Ltd
SZSE:000717
|
CN |
Income Statement
Earnings Waterfall
Sionna Therapeutics Inc
Sionna Therapeutics Inc
Income Statement
Sionna Therapeutics Inc
Sionna Therapeutics Inc
Currency: USD
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(71)
|
(90)
|
(112)
|
(84)
|
(89)
|
|
| Selling, General & Administrative |
(13)
|
(19)
|
(26)
|
(24)
|
(29)
|
|
| Research & Development |
(57)
|
(71)
|
(86)
|
(59)
|
(60)
|
|
| Operating Income |
(71)
N/A
|
(90)
-28%
|
(112)
-24%
|
(84)
+26%
|
(89)
-7%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
8
|
11
|
15
|
12
|
13
|
|
| Total Other Income |
1
|
1
|
1
|
1
|
0
|
|
| Pre-Tax Income |
(62)
N/A
|
(78)
-27%
|
(96)
-23%
|
(71)
+27%
|
(75)
-6%
|
|
| Net Income | ||||||
| Income from Continuing Operations |
(62)
|
(78)
|
(96)
|
(71)
|
(75)
|
|
| Net Income (Common) |
(62)
N/A
|
(78)
-27%
|
(96)
-23%
|
(71)
+27%
|
(75)
-6%
|
|
| EPS (Diluted) |
-1.45
N/A
|
-1.77
-22%
|
-2.18
-23%
|
-1.61
+26%
|
-1.88
-17%
|
|
Switch to:
Switch to:
See Also
Discover More
